Status:
COMPLETED
Hyperdynamic Left Ventricular Ejection Fraction as a Predictor of Mortality in Intensive Care Unit Patients With Septic Shock
Lead Sponsor:
Ain Shams University
Conditions:
Hyperdynamic
Left Ventricular Ejection Fraction
Eligibility:
All Genders
18+ years
Brief Summary
The study aimed to evaluate the cause and prognosis of hyperdynamic left ventricular ejection fraction in critically ill patients with sepsis.
Detailed Description
Cardiovascular dysfunction is increasingly being recognized as a significant complication in sepsis, affecting patient outcomes. Among the key parameters used to evaluate cardiac performance is the l...
Eligibility Criteria
Inclusion
- Age over 18 years.
- Both sexes.
- Patients who were diagnosed with septic shock.
Exclusion
- \- Patients with previously documented abnormal transthoracic echocardiography (TTE) findings, such as severe valvular disease, poor echocardiographic windows, patients admitted to cardiothoracic intensive care unit (ICU), and those not meeting sepsis criteria.
Key Trial Info
Start Date :
August 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2023
Estimated Enrollment :
235 Patients enrolled
Trial Details
Trial ID
NCT06993948
Start Date
August 1 2022
End Date
July 1 2023
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Egypt, 11591